Bio-Degradable Stents: Primary Experience in a Tertiary Hepatopancreaticobiliary Center in the United Kingdom

Osborne P Vaz; Shofiq Al-Islam; Zahid A Khan; Neil Wilde; Beverley Lowe; Anna Magilton; Daren A Subar

doi:10.7759/cureus.19075

Bio-Degradable Stents: Primary Experience in a Tertiary Hepatopancreaticobiliary Center in the United Kingdom

Cureus. 2021 Oct 27;13(10):e19075. doi: 10.7759/cureus.19075. eCollection 2021 Oct.

Authors

Osborne P Vaz¹, Shofiq Al-Islam², Zahid A Khan², Neil Wilde², Beverley Lowe³, Anna Magilton³, Daren A Subar⁴

Affiliations

¹ General Surgery, East Lancashire Hospital Trust, Blackburn, GBR.
² Radiology, East Lancashire Hospital Trust, Blackburn, GBR.
³ Radiodiagnosis, East Lancashire Hospital Trust, Blackburn, GBR.
⁴ Hepatobiliary and Pancreatic Surgery, East Lancashire Hospital Trust, Blackburn, GBR.

Abstract

Background: Management of benign biliary strictures (BBS) post bilioenteric anastomoses requires a multidisciplinary approach including surgical, radiological, and/or endoscopic input. Patients often need multiple hospital visits for treatment with the long-term possibility of restenosis. Conventionally BBS have been treated with serial percutaneous transhepatic biliary dilatations necessitating repeat procedures for drain exchange or removal. Surgery may become necessary in refractory strictures. In the last decade, there have been increasing reports of the use of biodegradable stents (BDS) in treating biliary strictures mainly to address the need for repeated procedures for drain exchange.

Aim: This study aimed to report the early outcomes in patients with BBS treated with BDS.

Methods: Retrospective analysis of prospectively collected data was performed in patients who had a bilioenteric anastomosis presenting with an anastomotic stricture and were intended to be treated with BDS. The primary endpoints reported were technical success (defined as a successful resolution of stricture on repeat cholangiogram) and clinical success (defined as the absence of repeated cholangitis). Clavien-Dindo (CD) grade of complication was reported.

Results: Twelve patients presented with BBS and nine patients had BDS. Three patients were not considered suitable for BDS due to a non-traversable stricture and had surgery. The male-female ratio was 1:2. There was 100% technical and clinical success with one patient having stent migration not needing intervention. The procedure took an average of 45 min. In seven (77.7%) patients, it was safely performed under local anesthesia with sedation. Two patients preferred general anesthesia. There was no restenosis noted at a median follow-up of 11 months.

Conclusion: The use of BDS in the treatment of BBS is a safe and effective procedure. Longer-term follow-up with multi-institutional reporting on a national database is needed to assess its long-term benefits.

Keywords: benign biliary strictures; bilioenteric anastomosis; biodegradable stents; endoscopic retrograde cholangiopancreatography (ercp); percutaneous transhepatic cholangiography.